Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts

Saved in:

Bibliographic Details
Published in	American journal of hematology Vol. 97; no. 12; pp. E474 - E477
Main Authors	Gangat, Naseema, Chetram, Deandra, McCullough, Kristen, Al‐Kali, Aref, Begna, Kebede, Hogan, William, Litzow, Mark, Foran, James, Badar, Talha, Palmer, Jeanne, Patnaik, Mrinal, Pardanani, Animesh, Tefferi, Ayalew
Format	Journal Article
Language	English
Published	Hoboken, USA John Wiley & Sons, Inc 01.12.2022 Wiley Subscription Services, Inc
Subjects	Activin Receptors, Type II Humans Myelodysplastic syndrome Myelodysplastic syndromes Myelodysplastic Syndromes - drug therapy Myelofibrosis Neoplasms Primary Myelofibrosis - drug therapy Sideroblasts
Online Access	Get full text
ISSN	0361-8609 1096-8652 1096-8652
DOI	10.1002/ajh.26749

More Information
Bibliography:	Naseema Gangat and Deandra Chetram are co‐first authors and contributed equally to this study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Correspondence-1
ISSN:	0361-8609 1096-8652 1096-8652
DOI:	10.1002/ajh.26749